US Stock MarketDetailed Quotes

Kyverna Therapeutics (KYTX)

Watchlist
  • 9.470
  • +0.260+2.82%
Close May 6 16:00 ET
  • 9.700
  • +0.230+2.43%
Pre 04:38 ET
573.22MMarket Cap-2.60P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kyverna Therapeutics (KYTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
19.09%169.83M
-4.29%39.28M
-0.11%38.73M
32.82%44.41M
61.48%47.41M
128.51%142.6M
91.99%41.04M
138.12%38.77M
151.35%33.44M
156.51%29.36M
Selling and administrative expenses
19.83%36.11M
22.63%9.27M
-13.65%8.27M
40.56%8.59M
44.94%9.98M
141.38%30.13M
79.35%7.56M
263.04%9.58M
111.05%6.11M
151.72%6.88M
-General and administrative expense
19.83%36.11M
22.63%9.27M
-13.65%8.27M
40.56%8.59M
44.94%9.98M
141.38%30.13M
79.35%7.56M
263.04%9.58M
111.05%6.11M
151.72%6.88M
Research and development costs
18.89%133.72M
-10.36%30.01M
4.33%30.46M
31.09%35.82M
66.55%37.43M
125.29%112.47M
95.09%33.48M
113.96%29.19M
162.58%27.32M
158.02%22.48M
Operating profit
-19.09%-169.83M
4.29%-39.28M
0.11%-38.73M
-32.82%-44.41M
-61.48%-47.41M
-128.51%-142.6M
-91.99%-41.04M
-138.12%-38.77M
-151.35%-33.44M
-156.51%-29.36M
Net non-operating interest income expense
-43.45%8.61M
-58.82%1.46M
-53.90%1.99M
-49.52%2.35M
4.05%2.8M
626.35%15.22M
378.17%3.55M
420.84%4.32M
2,035.32%4.66M
782.30%2.69M
Non-operating interest income
-40.79%9.09M
-46.71%1.91M
-54.08%2M
-49.64%2.36M
3.29%2.83M
573.05%15.36M
353.11%3.58M
394.89%4.36M
1,678.03%4.69M
683.67%2.74M
Non-operating interest expense
244.37%489K
1,544.44%444K
-78.13%7K
-64.10%14K
-43.18%25K
-24.06%142K
-42.55%27K
-36.00%32K
-15.22%39K
0.00%44K
Other net income (expense)
5.56%-85K
325.00%17K
-17.78%-53K
8.70%-21K
-3.85%-27K
-63.64%-90K
112.50%4K
-246.15%-45K
-228.57%-23K
-766.67%-26K
Other non- operating income (expenses)
5.56%-85K
325.00%17K
-17.78%-53K
8.70%-21K
-3.85%-27K
-63.64%-90K
112.50%4K
-246.15%-45K
-228.57%-23K
-766.67%-26K
Income before tax
-26.54%-161.31M
-0.84%-37.8M
-6.65%-36.79M
-46.10%-42.08M
-67.22%-44.64M
-111.17%-127.48M
-81.40%-37.49M
-123.03%-34.49M
-120.02%-28.8M
-139.55%-26.69M
Income tax
Net income
-26.54%-161.31M
-0.84%-37.8M
-6.65%-36.79M
-46.10%-42.08M
-67.22%-44.64M
-111.17%-127.48M
-81.40%-37.49M
-123.03%-34.49M
-120.02%-28.8M
-139.55%-26.69M
Net income continuous Operations
-26.54%-161.31M
-0.84%-37.8M
-6.65%-36.79M
-46.10%-42.08M
-67.22%-44.64M
-111.17%-127.48M
-81.40%-37.49M
-123.03%-34.49M
-120.02%-28.8M
-139.55%-26.69M
Minority interest income
Net income attributable to the parent company
-26.54%-161.31M
-0.84%-37.8M
-6.65%-36.79M
-46.10%-42.08M
-67.22%-44.64M
-111.17%-127.48M
-81.40%-37.49M
-123.03%-34.49M
-120.02%-28.8M
-139.55%-26.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-26.54%-161.31M
-0.84%-37.8M
-6.65%-36.79M
-46.10%-42.08M
-67.22%-44.64M
-111.17%-127.48M
-81.40%-37.49M
-123.03%-34.49M
-120.02%-28.8M
-139.55%-26.69M
Basic earnings per share
-9.31%-3.64
9.09%-0.8
-6.25%-0.85
-44.78%-0.97
8.04%-1.03
-125.19%-3.33
-73.82%-0.88
-111.17%-0.8
-108.93%-0.67
-159.36%-1.12
Diluted earnings per share
-9.31%-3.64
9.09%-0.8
-6.25%-0.85
-44.78%-0.97
8.04%-1.03
-125.19%-3.33
-73.82%-0.88
-111.17%-0.8
-108.93%-0.67
-159.36%-1.12
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 19.09%169.83M-4.29%39.28M-0.11%38.73M32.82%44.41M61.48%47.41M128.51%142.6M91.99%41.04M138.12%38.77M151.35%33.44M156.51%29.36M
Selling and administrative expenses 19.83%36.11M22.63%9.27M-13.65%8.27M40.56%8.59M44.94%9.98M141.38%30.13M79.35%7.56M263.04%9.58M111.05%6.11M151.72%6.88M
-General and administrative expense 19.83%36.11M22.63%9.27M-13.65%8.27M40.56%8.59M44.94%9.98M141.38%30.13M79.35%7.56M263.04%9.58M111.05%6.11M151.72%6.88M
Research and development costs 18.89%133.72M-10.36%30.01M4.33%30.46M31.09%35.82M66.55%37.43M125.29%112.47M95.09%33.48M113.96%29.19M162.58%27.32M158.02%22.48M
Operating profit -19.09%-169.83M4.29%-39.28M0.11%-38.73M-32.82%-44.41M-61.48%-47.41M-128.51%-142.6M-91.99%-41.04M-138.12%-38.77M-151.35%-33.44M-156.51%-29.36M
Net non-operating interest income expense -43.45%8.61M-58.82%1.46M-53.90%1.99M-49.52%2.35M4.05%2.8M626.35%15.22M378.17%3.55M420.84%4.32M2,035.32%4.66M782.30%2.69M
Non-operating interest income -40.79%9.09M-46.71%1.91M-54.08%2M-49.64%2.36M3.29%2.83M573.05%15.36M353.11%3.58M394.89%4.36M1,678.03%4.69M683.67%2.74M
Non-operating interest expense 244.37%489K1,544.44%444K-78.13%7K-64.10%14K-43.18%25K-24.06%142K-42.55%27K-36.00%32K-15.22%39K0.00%44K
Other net income (expense) 5.56%-85K325.00%17K-17.78%-53K8.70%-21K-3.85%-27K-63.64%-90K112.50%4K-246.15%-45K-228.57%-23K-766.67%-26K
Other non- operating income (expenses) 5.56%-85K325.00%17K-17.78%-53K8.70%-21K-3.85%-27K-63.64%-90K112.50%4K-246.15%-45K-228.57%-23K-766.67%-26K
Income before tax -26.54%-161.31M-0.84%-37.8M-6.65%-36.79M-46.10%-42.08M-67.22%-44.64M-111.17%-127.48M-81.40%-37.49M-123.03%-34.49M-120.02%-28.8M-139.55%-26.69M
Income tax
Net income -26.54%-161.31M-0.84%-37.8M-6.65%-36.79M-46.10%-42.08M-67.22%-44.64M-111.17%-127.48M-81.40%-37.49M-123.03%-34.49M-120.02%-28.8M-139.55%-26.69M
Net income continuous Operations -26.54%-161.31M-0.84%-37.8M-6.65%-36.79M-46.10%-42.08M-67.22%-44.64M-111.17%-127.48M-81.40%-37.49M-123.03%-34.49M-120.02%-28.8M-139.55%-26.69M
Minority interest income
Net income attributable to the parent company -26.54%-161.31M-0.84%-37.8M-6.65%-36.79M-46.10%-42.08M-67.22%-44.64M-111.17%-127.48M-81.40%-37.49M-123.03%-34.49M-120.02%-28.8M-139.55%-26.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -26.54%-161.31M-0.84%-37.8M-6.65%-36.79M-46.10%-42.08M-67.22%-44.64M-111.17%-127.48M-81.40%-37.49M-123.03%-34.49M-120.02%-28.8M-139.55%-26.69M
Basic earnings per share -9.31%-3.649.09%-0.8-6.25%-0.85-44.78%-0.978.04%-1.03-125.19%-3.33-73.82%-0.88-111.17%-0.8-108.93%-0.67-159.36%-1.12
Diluted earnings per share -9.31%-3.649.09%-0.8-6.25%-0.85-44.78%-0.978.04%-1.03-125.19%-3.33-73.82%-0.88-111.17%-0.8-108.93%-0.67-159.36%-1.12
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.63%
Sample Name
Sample Code
 +11.47%
Sample Name
Sample Code
 +8.64%
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+8.15%
5
United States Oil Fund LP
USO
+7.52%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +27.18%
Sample Name
Sample Code
 +19.45%
Sample Name
Sample Code
 +17.44%
4
Baidu
BIDU
+16.18%
5
Kingsoft Cloud
KC
+11.69%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -